These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 25855554)

  • 61. Effect of vaccination with a modified-live porcine reproductive and respiratory syndrome virus vaccine on dynamics of homologous viral infection in pigs.
    Cano JP; Dee SA; Murtaugh MP; Trincado CA; Pijoan CB
    Am J Vet Res; 2007 May; 68(5):565-71. PubMed ID: 17472459
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparative evaluation of 4 commercial modified-live porcine reproductive and respiratory syndrome virus (PRRSV) vaccines against heterologous dual Korean PRRSV-1 and PRRSV-2 challenge.
    Oh T; Park SJ; Cho H; Yang S; Ham HJ; Chae C
    Vet Med Sci; 2020 Nov; 6(4):846-853. PubMed ID: 32437071
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
    Dwivedi V; Manickam C; Patterson R; Dodson K; Murtaugh M; Torrelles JB; Schlesinger LS; Renukaradhya GJ
    Vaccine; 2011 May; 29(23):4058-66. PubMed ID: 21419162
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine.
    Opriessnig T; McKeown NE; Harmon KL; Meng XJ; Halbur PG
    Clin Vaccine Immunol; 2006 Aug; 13(8):923-9. PubMed ID: 16893993
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges.
    Geldhof MF; Vanhee M; Van Breedam W; Van Doorsselaere J; Karniychuk UU; Nauwynck HJ
    BMC Vet Res; 2012 Oct; 8():182. PubMed ID: 23031319
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate.
    Cano JP; Dee SA; Murtaugh MP; Pijoan C
    Vaccine; 2007 May; 25(22):4382-91. PubMed ID: 17451850
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intranasal delivery of an adjuvanted modified live porcine reproductive and respiratory syndrome virus vaccine reduces ROS production.
    Binjawadagi B; Dwivedi V; Manickam C; Torrelles JB; Renukaradhya GJ
    Viral Immunol; 2011 Dec; 24(6):475-82. PubMed ID: 22111597
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of antigenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV) in a modified live-attenuated porcine circovirus type 2 (PCV2) vaccine virus (PCV1-2a) as a potential bivalent vaccine against both PCV2 and PRRSV.
    Piñeyro PE; Kenney SP; Giménez-Lirola LG; Heffron CL; Matzinger SR; Opriessnig T; Meng XJ
    Virus Res; 2015 Dec; 210():154-64. PubMed ID: 26239318
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of four commercial PRRSV MLV vaccines in herds with co-circulation of PRRSV-1 and PRRSV-2.
    Oh T; Kim H; Park KH; Jeong J; Yang S; Kang I; Chae C
    Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():66-73. PubMed ID: 30961820
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs.
    Nilubol D; Platt KB; Halbur PG; Torremorell M; Harris DL
    Vet Microbiol; 2004 Aug; 102(1-2):11-8. PubMed ID: 15288922
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vaccination against porcine reproductive and respiratory syndrome virus (PRRSV) reduces the magnitude and duration of viremia following challenge with a virulent heterologous field strain.
    Calvert JG; Keith ML; Pearce DS; Lenz MC; King VL; Diamondidis YA; Ankenbauer RG; Martinon NC
    Vet Microbiol; 2017 Jun; 205():80-83. PubMed ID: 28622868
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
    Zhang Z; Wang Y; Fan H; Lu C
    Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Vaccine efficacy of porcine reproductive and respiratory syndrome virus chimeras.
    Ellingson JS; Wang Y; Layton S; Ciacci-Zanella J; Roof MB; Faaberg KS
    Vaccine; 2010 Mar; 28(14):2679-86. PubMed ID: 20064475
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Concurrent vaccinations against PCV2 and PRRSV: study on the specific immunity and clinical protection in naturally infected pigs.
    Martelli P; Ardigò P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Luppi A; Guazzetti S; Caleffi A; Borghetti P
    Vet Microbiol; 2013 Mar; 162(2-4):558-571. PubMed ID: 23206413
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transdermal delivery of plasmid encoding truncated nucleocapsid protein enhanced PRRSV-specific immune responses.
    Suradhat S; Wongyanin P; Sirisereewan C; Nedumpun T; Lumyai M; Triyarach S; Chaturavittawong D; Paphavasit T; Panyatong R; Thanawongnuwech R
    Vaccine; 2016 Jan; 34(5):609-615. PubMed ID: 26724543
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficacy evaluation of two commercial modified-live virus vaccines against a novel recombinant type 2 porcine reproductive and respiratory syndrome virus.
    Sun YF; Zhou L; Bian T; Tian XX; Ren WK; Lu C; Zhang L; Li XL; Cui MS; Yang HC; Yu H
    Vet Microbiol; 2018 Mar; 216():176-182. PubMed ID: 29519513
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of the new commercial recombinant chimeric subunit vaccine PRRSFREE in challenge with heterologous types 1 and 2 porcine reproductive and respiratory syndrome virus.
    Jeong J; Park C; Choi K; Chae C
    Can J Vet Res; 2017 Jan; 81(1):12-21. PubMed ID: 28154457
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Safety of PRRSV-2 MLV vaccines administrated via the intramuscular or intradermal route and evaluation of PRRSV transmission upon needle-free and needle delivery.
    Madapong A; Saeng-Chuto K; Tantituvanont A; Nilubol D
    Sci Rep; 2021 Nov; 11(1):23107. PubMed ID: 34845289
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Porcine reproductive and respiratory syndrome virus (PRRSv) modified-live vaccine reduces virus transmission in experimental conditions.
    Rose N; Renson P; Andraud M; Paboeuf F; Le Potier MF; Bourry O
    Vaccine; 2015 May; 33(21):2493-9. PubMed ID: 25820061
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy.
    Labarque G; Reeth KV; Nauwynck H; Drexler C; Van Gucht S; Pensaert M
    Vaccine; 2004 Oct; 22(31-32):4183-90. PubMed ID: 15474708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.